Smoltek Semi Nears Pilot Production of CNF-MIM Capacitors

Smoltek Nanotech Holding AB announces that its subsidiary, Smoltek Semi, is approaching pilot production of CNF-MIM capacitors. This development is part of the collaboration with the Taiwanese research institute, Industrial Technology Research Institute (ITRI). Together, the partners have established the technical framework for setting up a pilot production line – a milestone towards the future industrialization of the capacitor technology.

In early March, Smoltek Semi’s management visited ITRI to finalize the technical details for establishing a pilot production line for Smoltek’s CNF-MIM capacitors. The framework includes several time-bound project blocks, with each step carefully planned and evaluated to ensure a stable and efficient development process. Concurrently, the development of Smoltek’s CNF-MIM technology continues, with each prototype generation – currently CNF-MIM Gen-One – being tested and improved in multiple iterations to optimize performance.

The establishment of pilot production is a crucial part of Smoltek Semi’s strategy to enable future volume production of CNF-MIM capacitors, a technology that addresses the semiconductor industry’s growing need for high-performance and space-saving solutions.

About ITRI

ITRI is a world-leading research institute in applied technology with over 6,000 employees, primarily in Taiwan, Japan, the USA, and Germany. ITRI is a key player in semiconductor research and development, with state-of-the-art facilities for testing and scaling up the production of semiconductor components.

For Further Information

Håkan Persson, CEO, Smoltek Nanotech Holding AB
Email: hakan.persson@smoltek.com
Phone: 031 701 03 05
Website: www.smoltek.com/investors

Smoltek develops new products with disruptive performance, based on nanotechnology, that solve advanced material technology problems in several industry sectors and is currently active in two business areas: semiconductors and hydrogen. The company protects its unique carbon nanotechnology through an extensive patent portfolio consisting of approximately 110 patent applications, of which 94 are currently granted. Smoltek’s share is listed on Spotlight Stock Market under the ticker symbol SMOL. Smoltek is a development company and forward-looking statements regarding time to market, production volume and price levels should be interpreted as forecasts and not commitments.

---

Enjoyed this post by Thibault Helle? Subscribe for more insights and updates straight from the source.